← Leaderboards
John D Kriesel
University Of Utah
$2,453,399
Attributed
$4,782,721
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$4,782,721 · 5
By mechanism
U01$3,493,983 · 1
R03$597,403 · 2
R21$411,021 · 1
R29$280,314 · 1
Top collaborators
- Carrie L Byington4 shared
- Robert John Crisp4 shared
Most similar at University Of Utah
Same institution · by research overlap
- Carrie L Byington$13,399,303
Others in their field
Top investigators on “Pathogen”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$343,790,695
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
- Jeffrey P Krischer · University Of South Florida$130,496,919
- Mark S Klempner · Tufts Medical Center$128,021,180
- Timothy Stedman · American Type Culture Collection$122,230,581
- Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai$99,962,183
Research focus
PathogenSamplingGene TargetingFamilyFollow-UpBaseCommunitiesRelapse /RecurrenceLaboratory MouseGene ExpressionGene MutationHerpesvirus 1, HumanHomelessnessFreeze DryingGuanidiniumDiagnosisHealthcareClinicCohort StudiesCitiesElementary SchoolEmerging TechnologiesGenetic TranscriptionEnvironment And Public Health
Grant awards (14)
Defining the Microbiology of Sarcoidosis$76,250
R03 · FY2019 · AI · contact PI
Defining the Microbiology of Sarcoidosis$76,166
R03 · FY2018 · AI · contact PI
STI and Respiratory Pathogen testing in nontraditional settings$885,081
U01 · FY2012 · AI
Deep Sequencing for the Detection of Viral Sequences in Primary Progressive Multi$186,771
R21 · FY2012 · NS · contact PI
STI and Respiratory Pathogen testing in nontraditional settings$858,019
U01 · FY2011 · AI
Deep Sequencing for the Detection of Viral Sequences in Primary Progressive Multi$224,250
R21 · FY2011 · NS · contact PI
STI and Respiratory Pathogen testing in nontraditional settings$927,387
U01 · FY2010 · AI
STI and Respiratory Pathogen testing in nontraditional settings$823,496
U01 · FY2009 · AI
A Novel Genetic Therapy for Herpes Keratitis$145,987
R03 · FY2006 · EY · contact PI
A Novel Genetic Therapy for Herpes Keratitis$149,500
R03 · FY2005 · EY
A Novel Genetic Therapy for Herpes Keratitis$149,500
R03 · FY2004 · EY
IL-6 IN HERPES SIMPLEX VIRUS TYPE 1 OCULAR REACTIVATION$93,438
R29 · FY2002 · EY
IL-6 IN HERPES SIMPLEX VIRUS TYPE 1 OCULAR REACTIVATION$93,438
R29 · FY2001 · EY
IL-6 IN HERPES SIMPLEX VIRUS TYPE 1 OCULAR REACTIVATION$93,438
R29 · FY2000 · EY